Colombia vs Namibia: HIV/AIDS deaths averted by antiretroviral therapy
Colombia
11,670 deaths
in 2023
Namibia
11,508 deaths
in 2024
Colombia rank
21st
Namibia rank
22nd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Colombia
- Namibia
How they compare
Colombia currently reports 11,670 deaths against 11,508 deaths in Namibia, a difference of 162 deaths.
The two have swapped places 3 times across 34 shared years of data; in 1990 it was Namibia ahead.
Colombia ranks 21st and Namibia ranks 22nd of 157 countries.
Namibia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Colombia | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 1,534 deaths | 3,179 deaths | 1,645 deaths | Namibia |
| 2010s | 6,492 deaths | 10,813 deaths | 4,321 deaths | Namibia |
| 2020s | 10,904 deaths | 11,391 deaths | 486.93 deaths | Namibia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Colombia or Namibia?
- Colombia, at 11,670 deaths against 11,508 deaths in Namibia as of 2023.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Colombia and Namibia?
- 162 deaths, with Colombia ahead.
- How many years of comparable data are there for Colombia and Namibia?
- 34 years are reported by both, from 1990 to 2023.
- How do Colombia and Namibia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Colombia ranks 21st and Namibia ranks 22nd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.